• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Report: 1Q Pharma Deals Exceed Total for 2008

Mergers and acquisitions (M&A) in the pharmaceutical industry during the first quarter of 2009 exceeded the total dollar value of all pharma deals in 2008, according to the Associated Press (AP). AP says a report from The Mergermarket Group of New York and London puts the total for deals during the January 1 to March 31 period at $166 billion, more than 10 times the value of the same quarter in 2008 and well over the $114 billion total for the entire year. Three of the first-quarter deals include the Roche Group's purchase for $47 billion of the 44 percent of Genentech that it did not already own; Pfizer's $64 billion purchase of Wyeth; and Merck's acquisition of Schering-Plough for $43 billion. The report suggests that there will be several additional "mid-market" deals -- transactions valued at less than $5 billion -- over the next few quarters and some that involve smaller, targeted deals that fit with individual companies' growth strategies. Another prediction in the report is that M&A activity will increase among companies involved in stem cell research, following President Barack Obama's executive order in March to allow the use of federal funding for that research.

Follow Area Development